A citation-based method for searching scientific literature

Armando M Marrufo, Stephen O Mathew, Pankaj Chaudhary, Joseph D Malaer, Jamboor K Vishwanatha, Porunelloor A Mathew. Am J Cancer Res 2018
Times Cited: 24







List of co-cited articles
178 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Overexpression of LLT1 (OCIL, CLEC2D) on prostate cancer cells inhibits NK cell-mediated killing through LLT1-NKRP1A (CD161) interaction.
Stephen O Mathew, Pankaj Chaudhary, Sheila B Powers, Jamboor K Vishwanatha, Porunelloor A Mathew. Oncotarget 2016
28
45

Cutting edge: lectin-like transcript-1 is a ligand for the inhibitory human NKR-P1A receptor.
David B Rosen, Jayaram Bettadapura, Mohammed Alsharifi, Porunelloor A Mathew, Hilary S Warren, Lewis L Lanier. J Immunol 2005
194
41

Expression of LLT1 and its receptor CD161 in lung cancer is associated with better clinical outcome.
Véronique M Braud, Jérôme Biton, Etienne Becht, Samantha Knockaert, Audrey Mansuet-Lupo, Estelle Cosson, Diane Damotte, Marco Alifano, Pierre Validire, Fabienne Anjuère,[...]. Oncoimmunology 2018
27
33

Cutting edge: lectin-like transcript 1 is a ligand for the CD161 receptor.
Hatice Aldemir, Virginie Prod'homme, Marie-Jeanne Dumaurier, Christelle Retiere, Gwenola Poupon, Julie Cazareth, Franck Bihl, Veronique M Braud. J Immunol 2005
198
29

Functional consequences of interactions between human NKR-P1A and its ligand LLT1 expressed on activated dendritic cells and B cells.
David B Rosen, Wei Cao, Danielle T Avery, Stuart G Tangye, Yong-Jun Liu, J P Houchins, Lewis L Lanier. J Immunol 2008
116
29

Cloning of a new lectin-like receptor expressed on human NK cells.
K S Boles, R Barten, P R Kumaresan, J Trowsdale, P A Mathew. Immunogenetics 1999
53
25

LLT1 and CD161 Expression in Human Germinal Centers Promotes B Cell Activation and CXCR4 Downregulation.
Alba Llibre, Constantino López-Macías, Teresa Marafioti, Hema Mehta, Amy Partridge, Carina Kanzig, Felice Rivellese, Jacob D Galson, Lucy J Walker, Paul Milne,[...]. J Immunol 2016
26
20

Malignant glioma cells counteract antitumor immune responses through expression of lectin-like transcript-1.
Patrick Roth, Michel Mittelbronn, Wolfgang Wick, Richard Meyermann, Marcos Tatagiba, Michael Weller. Cancer Res 2007
67
20

Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells.
Pascale André, Caroline Denis, Caroline Soulas, Clarisse Bourbon-Caillet, Julie Lopez, Thomas Arnoux, Mathieu Bléry, Cécile Bonnafous, Laurent Gauthier, Ariane Morel,[...]. Cell 2018
514
20

The LLT1 receptor induces IFN-gamma production by human natural killer cells.
Porunelloor A Mathew, Samuel S Chuang, Swapnil V Vaidya, Pappanaicken R Kumaresan, Kent S Boles, Hoang-Tuan K Pham. Mol Immunol 2004
36
20

Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis.
Nathan D Mathewson, Orr Ashenberg, Itay Tirosh, Simon Gritsch, Elizabeth M Perez, Sascha Marx, Livnat Jerby-Arnon, Rony Chanoch-Myers, Toshiro Hara, Alyssa R Richman,[...]. Cell 2021
74
20

Multi-functional lectin-like transcript-1: A new player in human immune regulation.
Alba Llibre, Paul Klenerman, Christian B Willberg. Immunol Lett 2016
13
30

Targeting natural killer cells in cancer immunotherapy.
Camille Guillerey, Nicholas D Huntington, Mark J Smyth. Nat Immunol 2016
614
16

Functions of natural killer cells.
Eric Vivier, Elena Tomasello, Myriam Baratin, Thierry Walzer, Sophie Ugolini. Nat Immunol 2008
16

NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control.
Jan P Böttcher, Eduardo Bonavita, Probir Chakravarty, Hanna Blees, Mar Cabeza-Cabrerizo, Stefano Sammicheli, Neil C Rogers, Erik Sahai, Santiago Zelenay, Caetano Reis e Sousa. Cell 2018
712
16

Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity.
Qing Zhang, Jiacheng Bi, Xiaodong Zheng, Yongyan Chen, Hua Wang, Wenyong Wu, Zhengguang Wang, Qiang Wu, Hui Peng, Haiming Wei,[...]. Nat Immunol 2018
462
16


Induction of lectin-like transcript 1 (LLT1) protein cell surface expression by pathogens and interferon-γ contributes to modulate immune responses.
Claire Germain, Anders Meier, Teis Jensen, Perrine Knapnougel, Gwenola Poupon, Anne Lazzari, Anne Neisig, Katarina Håkansson, Tao Dong, Nicolai Wagtmann,[...]. J Biol Chem 2011
86
16

Lectin-like transcript 1 is a marker of germinal center-derived B-cell non-Hodgkin's lymphomas dampening natural killer cell functions.
Claire Germain, Thierry Guillaudeux, Elisabeth D Galsgaard, Catherine Hervouet, Nedra Tekaya, Anne-Sophie Gallouet, Julien Fassy, Franck Bihl, Gwenola Poupon, Anne Lazzari,[...]. Oncoimmunology 2015
26
16

Biological and Clinical Significance of Human NKRP1A/LLT1 Receptor/Ligand Interactions.
Agata Bialoszewska, Jacek Malejczyk. Crit Rev Immunol 2018
15
26

CS1 (SLAMF7, CD319) is an effective immunotherapeutic target for multiple myeloma.
Joseph D Malaer, Porunelloor A Mathew. Am J Cancer Res 2017
49
16


CD161 Defines a Functionally Distinct Subset of Pro-Inflammatory Natural Killer Cells.
Ayako Kurioka, Cormac Cosgrove, Yannick Simoni, Bonnie van Wilgenburg, Alessandra Geremia, Sophia Björkander, Eva Sverremark-Ekström, Christine Thurnheer, Huldrych F Günthard, Nina Khanna,[...]. Front Immunol 2018
48
16

Characterization of alternatively spliced transcript variants of CLEC2D gene.
Claire Germain, Franck Bihl, Stefan Zahn, Gwenola Poupon, Marie-Jeanne Dumaurier, Hariniaina Henintsoa Rampanarivo, Søren Berg Padkjær, Pieter Spee, Veronique M Braud. J Biol Chem 2010
37
16

Expression of Lectin-Like Transcript 1, the Ligand for CD161, in Rheumatoid Arthritis.
Paulina Chalan, Johan Bijzet, Minke G Huitema, Bart-Jan Kroesen, Elisabeth Brouwer, Annemieke M H Boots. PLoS One 2015
11
27

Expression of lectin-like transcript-1 in human tissues.
Alba Llibre, Lucy Garner, Amy Partridge, Gordon J Freeman, Paul Klenerman, Chris B Willberg. F1000Res 2016
11
27

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants.
Loredana Ruggeri, Marusca Capanni, Elena Urbani, Katia Perruccio, Warren D Shlomchik, Antonella Tosti, Sabrina Posati, Daniela Rogaia, Francesco Frassoni, Franco Aversa,[...]. Science 2002
12

Global cancer statistics, 2012.
Lindsey A Torre, Freddie Bray, Rebecca L Siegel, Jacques Ferlay, Joannie Lortet-Tieulent, Ahmedin Jemal. CA Cancer J Clin 2015
12

Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade.
Joy Hsu, Jonathan J Hodgins, Malvika Marathe, Chris J Nicolai, Marie-Claude Bourgeois-Daigneault, Troy N Trevino, Camillia S Azimi, Amit K Scheer, Haley E Randolph, Thornton W Thompson,[...]. J Clin Invest 2018
377
12

NK cell-based immunotherapy for cancer.
Fang Fang, Weihua Xiao, Zhigang Tian. Semin Immunol 2017
164
12

A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments.
Kevin C Barry, Joy Hsu, Miranda L Broz, Francisco J Cueto, Mikhail Binnewies, Alexis J Combes, Amanda E Nelson, Kimberly Loo, Raj Kumar, Michael D Rosenblum,[...]. Nat Med 2018
436
12

Reversal of NK-cell exhaustion in advanced melanoma by Tim-3 blockade.
Ines Pires da Silva, Anne Gallois, Sonia Jimenez-Baranda, Shaukat Khan, Ana C Anderson, Vijay K Kuchroo, Iman Osman, Nina Bhardwaj. Cancer Immunol Res 2014
234
12


Elotuzumab enhances natural killer cell activation and myeloma cell killing through interleukin-2 and TNF-α pathways.
Balaji Balasa, Rui Yun, Nicole A Belmar, Melvin Fox, Debra T Chao, Michael D Robbins, Gary C Starling, Audie G Rice. Cancer Immunol Immunother 2015
106
12

Anti-CS1 humanized monoclonal antibody HuLuc63 inhibits myeloma cell adhesion and induces antibody-dependent cellular cytotoxicity in the bone marrow milieu.
Yu-Tzu Tai, Myles Dillon, Weihua Song, Merav Leiba, Xian-Feng Li, Peter Burger, Alfred I Lee, Klaus Podar, Teru Hideshima, Audie G Rice,[...]. Blood 2008
358
12

Natural Killer Cells: Development, Maturation, and Clinical Utilization.
Alex M Abel, Chao Yang, Monica S Thakar, Subramaniam Malarkannan. Front Immunol 2018
392
12

NKG2D Ligands-Critical Targets for Cancer Immune Escape and Therapy.
Dominik Schmiedel, Ofer Mandelboim. Front Immunol 2018
75
12

MHC class I antigen processing and presenting machinery: organization, function, and defects in tumor cells.
Patrizia Leone, Eui-Cheol Shin, Federico Perosa, Angelo Vacca, Franco Dammacco, Vito Racanelli. J Natl Cancer Inst 2013
300
12

The Broad Spectrum of Human Natural Killer Cell Diversity.
Aharon G Freud, Bethany L Mundy-Bosse, Jianhua Yu, Michael A Caligiuri. Immunity 2017
314
12


The Emerging Role of CD244 Signaling in Immune Cells of the Tumor Microenvironment.
Laura Agresta, Kasper H N Hoebe, Edith M Janssen. Front Immunol 2018
57
12

Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity.
Ye Li, David L Hermanson, Branden S Moriarity, Dan S Kaufman. Cell Stem Cell 2018
394
12

Lectin-like transcript 1 (LLT1) expression is associated with nodal metastasis in patients with head and neck cutaneous squamous cell carcinoma.
J Santos-Juanes, I Fernández-Vega, S Lorenzo-Herrero, C Sordo-Bahamonde, P Martínez-Camblor, J M García-Pedrero, B Vivanco, C Galache-Osuna, F Vazquez-Lopez, S Gonzalez,[...]. Arch Dermatol Res 2019
7
42

The prognostic landscape of genes and infiltrating immune cells across human cancers.
Andrew J Gentles, Aaron M Newman, Chih Long Liu, Scott V Bratman, Weiguo Feng, Dongkyoon Kim, Viswam S Nair, Yue Xu, Amanda Khuong, Chuong D Hoang,[...]. Nat Med 2015
12

CD161 defines a transcriptional and functional phenotype across distinct human T cell lineages.
Joannah R Fergusson, Kira E Smith, Vicki M Fleming, Neil Rajoriya, Evan W Newell, Ruth Simmons, Emanuele Marchi, Sophia Björkander, Yu-Hoi Kang, Leo Swadling,[...]. Cell Rep 2014
187
12

Four crystal structures of human LLT1, a ligand of human NKR-P1, in varied glycosylation and oligomerization states.
Tereza Skálová, Jan Bláha, Karl Harlos, Jarmila Dušková, Tomáš Koval', Jan Stránský, Jindřich Hašek, Ondřej Vaněk, Jan Dohnálek. Acta Crystallogr D Biol Crystallogr 2015
16
18

Crystal structure of extracellular domain of human lectin-like transcript 1 (LLT1), the ligand for natural killer receptor-P1A.
Shunsuke Kita, Haruki Matsubara, Yoshiyuki Kasai, Takaharu Tamaoki, Yuki Okabe, Hideo Fukuhara, Jun Kamishikiryo, Elena Krayukhina, Susumu Uchiyama, Toyoyuki Ose,[...]. Eur J Immunol 2015
11
27

A2AR Adenosine Signaling Suppresses Natural Killer Cell Maturation in the Tumor Microenvironment.
Arabella Young, Shin Foong Ngiow, Yulong Gao, Ann-Marie Patch, Deborah S Barkauskas, Meriem Messaoudene, Gene Lin, Jerome D Coudert, Kimberley A Stannard, Laurence Zitvogel,[...]. Cancer Res 2018
162
12

Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3.
Jun Wang, Miguel F Sanmamed, Ila Datar, Tina Tianjiao Su, Lan Ji, Jingwei Sun, Ling Chen, Yusheng Chen, Gefeng Zhu, Weiwei Yin,[...]. Cell 2019
330
12

Cancer immunotherapy using checkpoint blockade.
Antoni Ribas, Jedd D Wolchok. Science 2018
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.